... these cancers,” the authors write.
Contact: Frank Viborg Mortensen, Fvmor@as.aaa.dk, +45 86 11 02 10
Also in the May 13 JNCI:
http://www.eurekalert.org/emb_releases/2008-05/jotn-pim050808.php
... 34-670580865 Editorial: Esther Napolitano, napolite@mskcc.org, (646) 227-3139
Also in May 27 JNCI: http://www.eurekalert.org/emb_releases/2008-05/jotn-asm052208.php http://www.eurekalert ...
... epidemiological studies," the authors write.
Contact: Judy Martin Finch, martinju@msnotes.wustl.edu
Also in the June 24 JNCI: • http://www.eurekalert.org/emb_releases/2008-06/jotn-aol061908.php
... 4146681 Editorial: Molly Johnson, johnsm@ccf.org, (216) 444-1815
Also in the August 26 JNCI: http://www.eurekalert.org/emb_releases/2008-08/jotn-aia082108.php http://www.eurekalert. ...
... conclude.
Contact: Gwen Ericson, ericsong@wustl.edu, (314) 286-0141
Also in the September 9 JNCI: http://www.eurekalert.org/emb_releases/2008-09/jotn-eoq090408.php http://www.eurekalert.org/ ...
... .
Contact: Scott Merville, SMerville@mdanderson.org, (713) 792-0661
Also in the September 23 JNCI: http://www.eurekalert.org/emb_releases/2008-09/jotn-nmp091808.php http://www.eurekalert. ...
... of media relations, ncipressofficers@mail.nih.gov, (301) 496-6641
Also in the October 7 JNCI: http://www.eurekalert.org/emb_releases/2008-10/jotn-orc100208.php http://www.eurekalert.org/ ...
... Elena Tamborini, Elena.Tamborini@istitutotumori.mi.it., +39 02 2390 2280
Also in the January 27 JNCI: http://www.eurekalert.org/emb_releases/2009-01/jotn-saa012309.php http://www.eurekalert.org/ ...
...
Contact: Bill Schaller, william_schaller@dfci.harvard.edu; (617) 632-5357
Also in the December 9 JNCI: http://www.eurekalert.org/emb_releases/2009-03/jotn-seo030509.php http://www.eurekalert.org ...
Novel Targeted Therapy Reduces Chemoresistance in Mouse Model of Melanoma A novel small molecule inhibitor reduced both endogenous and drug-induced resistance to chemotherapy in a mouse model of ...
The Same Dose of Anthracycline Is Not Safe for Everyone Not all patients can tolerate the currently recommended cumulative dose of epirubicin. New models can help physicians calculate the epirubicin ...
Hepatitis B Genotypes and Mutants May Influence Liver Cancer Risk Infection with hepatitis B virus (HBV) causes liver cancer in some individuals, but not all strains of the virus are associated with ...
No Association Between Fat, Protein, and Meat Consumption and Kidney Cancer There is no association between consumption of fat, protein, or meat and kidney cancer, according to a pooled analysis of ...
Pharmacokinetics May Explain Differences in Cisplatin and Oxaliplatin Ototoxicity More cisplatin enters the inner ear in an animal model than oxaliplatin. The difference may explain why cisplatin ...
Subsequent Malignancy a Major Cause of Death in Long-Term Survivors of Hereditary Retinoblastoma Long-term survivors of hereditary retinoblastoma are at an increased risk of death due to a second ...
